Premedication with fentanyl or fentanyl and midazolam for endoscopic retrograde cholangiopancreatography

Comparison of hemodynamic and respiratory effects of premedication with fentanyl or fentanyl and midazolam during anesthesia for endoscopic retrograde cholangiopancreatography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016031120795N2

Enrollment

Registered

2016-04-29

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis. Any condition listed in K80.2 with acute cholecystitis

Interventions

Intervention 1: Intervention group premedication with fentanyl 1 microgram/kg before anesthesia induction. Intervention 2: Control group premedication with fentanyl 1 microgram/kg and midazolam 0.02 m

Treatment - Drugs

Intervention group premedication with fentanyl 1 microgram/kg before anesthesia induction

Control group premedication with fentanyl 1 microgram/kg and midazolam 0.02 mg/kg before anesthesia induction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with ASA class I-III who will undergo endoscopic retrograde cholangiopancreatography(ERCP). Exclusion criteria: Emergency ERCP; Liver or kidney diseases; previous history of sedatives or tranquilizers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Respiratory effects. Timepoint: Before and instantly after intervention. Method of measurement: Apnea presence.	—

Secondary

Measure	Time frame
Hemodynamic effects. Timepoint: After intervention. Method of measurement: Blood pressure and Heart rate measuring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamad Golzari

Tabriz University of Medical Sciences

golzaris@tbzmed.ac.ir+98 41 3556 6183

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026